• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 21-03-2026: Press Release

    21-03-2026 | 11:57 am

    Sun Pharma launched semaglutide injection, Noveltreat (weight management) and Sematrinity (diabetes), in India. Priced significantly lower than innovator brands, weekly therapy costs range from ₹750 to ₹2,000, boosting affordability and market access.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited